Comparisons
Compare
Consistent, sourced side-by-sides of treatments and providers. We surface material differences and decision considerations — not a verdict on which is medically best.
Treatment vs. treatment
Semaglutide vs. Tirzepatide
Both are FDA-approved injectable incretin medications for type 2 diabetes and chronic weight management. Tirzepatide acts on two receptors (GIP and GLP-1); semaglutide acts on one (GLP-1). We do not state which is medically "best" — that depends on an individual's clinical picture.
Branded (FDA-approved) vs. Compounded Semaglutide
Branded semaglutide (Ozempic, Wegovy, Rybelsus) is FDA-approved and reviewed for safety, effectiveness, and quality. Compounded semaglutide is prepared by pharmacies and is NOT FDA-approved or reviewed. This is the single most important distinction for anyone considering a telehealth GLP-1 program.
Semaglutide vs. Liraglutide
Both are FDA-approved GLP-1 receptor agonists. The main practical differences are dosing frequency (weekly vs. daily) and that liraglutide (Saxenda) has an FDA weight-management indication for adolescents 12 and older.
Metformin vs. Rapamycin for longevity interest
Both are FDA-approved for other uses and attract off-label longevity interest. Neither is FDA-approved for aging. Metformin has a large trial (TAME) designed to test aging-related outcomes; rapamycin's longevity evidence is largely from animals.
BPC-157 vs. Tesamorelin: approval status matters
Both are peptides discussed in recovery and body-composition contexts, but their regulatory footing is very different. Tesamorelin is FDA-approved for a specific condition; BPC-157 is not FDA-approved for any use and lacks human trials.
Provider vs. provider
Ro vs. LifeMD for GLP-1 weight management
Two telehealth platforms offering clinician-supervised GLP-1 weight programs. Both use a first-month promotional fee then an ongoing monthly program/membership fee, with medication billed separately. Operational facts below were verified on each provider's official site on 2026-07-24.
Found vs. Mochi Health for compounded GLP-1 programs
Two telehealth platforms that offer compounded GLP-1 options alongside membership fees. Both disclose that compounded medications are not FDA-approved. Operational facts verified on each official site on 2026-07-24.